Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 1/2017

25.10.2015 | Short Communication

Driving skills in unmedicated first- and recurrent-episode schizophrenic patients

verfasst von: Felix M. Segmiller, Verena Buschert, Gerd Laux, N. Nedopil, Ulrich Palm, Katharina Furjanic, Peter Zwanzger, Alexander Brunnauer

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The present study was designed to examine driving skills according to regulations of the German guidelines for road and traffic safety in unmedicated schizophrenic inpatients. A total of 13 first-episode (FES) and 13 recurrent-episode (RES) schizophrenic inpatients were included in the analysis and compared with a group of 20 healthy controls (HC). Data were collected with the computerised Wiener Testsystem measuring visual perception, reactivity and stress tolerance, concentration and vigilance. Analysis of data indicates that a great proportion (58 %) of schizophrenic patients were impaired in psychomotor functions related to driving skills. FES and RES significantly differed with respect to driving ability with a greater proportion in the FES (38 %) showing severe impairments when compared with RES (25 %). Differences with respect to HC performance were most pronounced in concentration and for the FES additionally in visual perception. Analysis of our data indicates that a great proportion of schizophrenic patients are impaired in psychomotor functions related to driving skills that cannot be attributed to adverse side effects of psychopharmacological treatment. Besides, we cannot confirm a chronical decline of psychomotor functions related to driving skills at least in the early course of schizophrenic illness.
Literatur
1.
Zurück zum Zitat Palmer BW, Heaton RK, Gladsjo JA, Evans JD, Patterson TL, Golshan S, Jeste DV (2002) Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophr Res 55:205–215CrossRefPubMed Palmer BW, Heaton RK, Gladsjo JA, Evans JD, Patterson TL, Golshan S, Jeste DV (2002) Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophr Res 55:205–215CrossRefPubMed
2.
Zurück zum Zitat Brunnauer A, Laux G, Zwick S, David I, Schmauss M, Messer Th, Hermisson I, Möller HJ, Steinberg R, Frommberger U (2008) Mobilitätsverhalten psychiatrischer Patienten. Nervenheilkunde 27(Suppl 1):120–121 Brunnauer A, Laux G, Zwick S, David I, Schmauss M, Messer Th, Hermisson I, Möller HJ, Steinberg R, Frommberger U (2008) Mobilitätsverhalten psychiatrischer Patienten. Nervenheilkunde 27(Suppl 1):120–121
3.
Zurück zum Zitat Gibbons TCN (1976) Mental illness, personality and behaviour disorders. In: Raffle PAB (ed) Medical aspects of fitness to drive, 3rd edn. Medical Commission on Accident Prevention, London, pp 30–33 Gibbons TCN (1976) Mental illness, personality and behaviour disorders. In: Raffle PAB (ed) Medical aspects of fitness to drive, 3rd edn. Medical Commission on Accident Prevention, London, pp 30–33
5.
Zurück zum Zitat Edlund MJ, Conrad C, Morris P (1989) Accidents among schizophrenic outpatients. Compr Psychiatry 30(6):522–526CrossRefPubMed Edlund MJ, Conrad C, Morris P (1989) Accidents among schizophrenic outpatients. Compr Psychiatry 30(6):522–526CrossRefPubMed
6.
Zurück zum Zitat Charlton JL, Koppel S, O’Hare M, Andrea D, Smith G, Khodr B, Langford J, Odell M, Fildes B (2004) Influence of chronic illness on crash involvement of motor vehicle drivers. Monash University Accident Research Centre—Report, Swedish National Road Administration Charlton JL, Koppel S, O’Hare M, Andrea D, Smith G, Khodr B, Langford J, Odell M, Fildes B (2004) Influence of chronic illness on crash involvement of motor vehicle drivers. Monash University Accident Research Centre—Report, Swedish National Road Administration
7.
Zurück zum Zitat Eelkema RC, Bronssean J, Koshnick R, McGee C (1970) A statistical study on the relationship between mental illness and traffic accidents. Public Health 60:459–469 Eelkema RC, Bronssean J, Koshnick R, McGee C (1970) A statistical study on the relationship between mental illness and traffic accidents. Public Health 60:459–469
8.
Zurück zum Zitat Waller JA (1965) Chronic medical conditions and traffic safety: a review of the California experience. N Engl J Med 273:1413–1420CrossRefPubMed Waller JA (1965) Chronic medical conditions and traffic safety: a review of the California experience. N Engl J Med 273:1413–1420CrossRefPubMed
9.
Zurück zum Zitat Velligan DI, Miller AL (1999) Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment. J Clin Psychiatry 60(Suppl 23):25–28PubMed Velligan DI, Miller AL (1999) Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment. J Clin Psychiatry 60(Suppl 23):25–28PubMed
10.
Zurück zum Zitat Zihl J, Grön G, Brunnauer A (1998) Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder. Acta Psychiatr Scand 97(5):351–357CrossRefPubMed Zihl J, Grön G, Brunnauer A (1998) Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder. Acta Psychiatr Scand 97(5):351–357CrossRefPubMed
11.
Zurück zum Zitat Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12(3):426–445CrossRefPubMed Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12(3):426–445CrossRefPubMed
12.
Zurück zum Zitat Velligan DI, Prihoda TJ, Sui D, Ritch JL, Maples N, Miller AL (2003) The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 64(5):524–531CrossRefPubMed Velligan DI, Prihoda TJ, Sui D, Ritch JL, Maples N, Miller AL (2003) The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 64(5):524–531CrossRefPubMed
13.
Zurück zum Zitat Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72(1):41–51CrossRefPubMed Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72(1):41–51CrossRefPubMed
14.
Zurück zum Zitat Brunnauer A, Laux G, Geiger E, Möller HJ (2004) The impact of antipsychotics on psychomotor performance with regards to car driving skills. J Clin Psychopharmacol 24(2):155–160CrossRefPubMed Brunnauer A, Laux G, Geiger E, Möller HJ (2004) The impact of antipsychotics on psychomotor performance with regards to car driving skills. J Clin Psychopharmacol 24(2):155–160CrossRefPubMed
15.
Zurück zum Zitat Brunnauer A, Laux G (2012) Driving ability under sertindole. Pharmacopsychiatry 45(2):47–50CrossRefPubMed Brunnauer A, Laux G (2012) Driving ability under sertindole. Pharmacopsychiatry 45(2):47–50CrossRefPubMed
16.
Zurück zum Zitat Soyka M, Winter C, Kagerer S, Brunnauer M, Laux G, Möller HJ (2005) Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls. J Psychiatr Res 39(1):101–108CrossRefPubMed Soyka M, Winter C, Kagerer S, Brunnauer M, Laux G, Möller HJ (2005) Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls. J Psychiatr Res 39(1):101–108CrossRefPubMed
17.
Zurück zum Zitat Brunnauer A, Laux G, Zwick S (2009) Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics. Eur Arch Psychiatry Clin Neurosci 259(8):483–489CrossRefPubMed Brunnauer A, Laux G, Zwick S (2009) Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics. Eur Arch Psychiatry Clin Neurosci 259(8):483–489CrossRefPubMed
18.
Zurück zum Zitat Kagerer S, Winter C, Moeller HJ, Soyka M (2003) Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study. Neuropsychobiology 47:212–218CrossRefPubMed Kagerer S, Winter C, Moeller HJ, Soyka M (2003) Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study. Neuropsychobiology 47:212–218CrossRefPubMed
19.
Zurück zum Zitat Dittert S, Soyka M, Winter C, Moeller HJ (1999) Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol. Fortschr Neurol Psychiatr 67:S70–S73CrossRef Dittert S, Soyka M, Winter C, Moeller HJ (1999) Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol. Fortschr Neurol Psychiatr 67:S70–S73CrossRef
20.
Zurück zum Zitat Grabe HJ, Wolf T, Gratz S, Laux G (1999) The influence of clozapine and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: implications for fitness to drive. Neuropsychobiology 40:196–201CrossRefPubMed Grabe HJ, Wolf T, Gratz S, Laux G (1999) The influence of clozapine and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: implications for fitness to drive. Neuropsychobiology 40:196–201CrossRefPubMed
21.
Zurück zum Zitat Gräcmann N, Albrecht M (2014) Begutachtungsleitlinien zur Kraftfahreignung. Bundesanstalt für Straßenwesen. Berichte der Bundesanstalt für Straßenwesen. Mensch und Sicherheit. Heft M115. Bergisch Gladbach Gräcmann N, Albrecht M (2014) Begutachtungsleitlinien zur Kraftfahreignung. Bundesanstalt für Straßenwesen. Berichte der Bundesanstalt für Straßenwesen. Mensch und Sicherheit. Heft M115. Bergisch Gladbach
22.
Zurück zum Zitat Brunnauer A, Laux G, Geiger E, Soyka M, Möller HJ (2006) Antidepressants and driving ability: results from a clinical study. J Clin Psychiatry 67(11):1776–1781CrossRefPubMed Brunnauer A, Laux G, Geiger E, Soyka M, Möller HJ (2006) Antidepressants and driving ability: results from a clinical study. J Clin Psychiatry 67(11):1776–1781CrossRefPubMed
23.
Zurück zum Zitat Bukasa B, Christ R, Pocorny-Seliger E (2003) Validitätsprüfung verkehrspsychologischer Leistungstests für die Fahreignungsbeurteilung. Z Verkehrssicherheit 49:191–197 Bukasa B, Christ R, Pocorny-Seliger E (2003) Validitätsprüfung verkehrspsychologischer Leistungstests für die Fahreignungsbeurteilung. Z Verkehrssicherheit 49:191–197
24.
Zurück zum Zitat Bukasa B, Kisser R, Wenninger U (1990) Computergestützte Leistungsdiagnostik bei verkehrspsychologischen Eignungsuntersuchungen. Diagnostica 36:148–165 Bukasa B, Kisser R, Wenninger U (1990) Computergestützte Leistungsdiagnostik bei verkehrspsychologischen Eignungsuntersuchungen. Diagnostica 36:148–165
25.
Zurück zum Zitat Karner T, Biehl B (2001) Über die Zusammenhänge verschiedener Versionen von Leistungstests im Rahmen der verkehrspsychologischen Diagnostik. Z Verkehrssicherheit 42:53–63 Karner T, Biehl B (2001) Über die Zusammenhänge verschiedener Versionen von Leistungstests im Rahmen der verkehrspsychologischen Diagnostik. Z Verkehrssicherheit 42:53–63
26.
Zurück zum Zitat Cohen CI, Cohen GD, Blank K, Gaitz C, Katz IR, Leuchter A, Maletta G, Meyers B, Sakauye B, Shamoian C (2000) Schizophrenia and older adults. An overview: directions for research and policy. Am J Geriatr Psychiatry 8:19–28CrossRefPubMed Cohen CI, Cohen GD, Blank K, Gaitz C, Katz IR, Leuchter A, Maletta G, Meyers B, Sakauye B, Shamoian C (2000) Schizophrenia and older adults. An overview: directions for research and policy. Am J Geriatr Psychiatry 8:19–28CrossRefPubMed
27.
Zurück zum Zitat Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12(3):426–445CrossRefPubMed Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12(3):426–445CrossRefPubMed
28.
Zurück zum Zitat Gold JM (2004) Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 72(1):21–28CrossRefPubMed Gold JM (2004) Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 72(1):21–28CrossRefPubMed
29.
Zurück zum Zitat Zanelli J, Reichenberg A, Morgan K, Fearon P, Kravariti E, Dazzan P, Morgan C, Zanelli C, Demjaha A, Jones PB, Doody GA, Kapur S, Murray RM (2010) Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry 167(1):78–85CrossRefPubMed Zanelli J, Reichenberg A, Morgan K, Fearon P, Kravariti E, Dazzan P, Morgan C, Zanelli C, Demjaha A, Jones PB, Doody GA, Kapur S, Murray RM (2010) Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry 167(1):78–85CrossRefPubMed
30.
Zurück zum Zitat Bora E, Murray RM (2014) Meta-analysis of cognitive deficits in ultra high-risk to psychosis and first episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull 40:744–755CrossRefPubMed Bora E, Murray RM (2014) Meta-analysis of cognitive deficits in ultra high-risk to psychosis and first episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull 40:744–755CrossRefPubMed
31.
Zurück zum Zitat Albus M, Hubmann W, Mohr F, Hecht S, Hinterberger Weber P, Seitz NN, Küchenhoff H (2006) Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study. Eur Arch Psychiatry Clin Neurosci 256(7):442–451CrossRefPubMed Albus M, Hubmann W, Mohr F, Hecht S, Hinterberger Weber P, Seitz NN, Küchenhoff H (2006) Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study. Eur Arch Psychiatry Clin Neurosci 256(7):442–451CrossRefPubMed
32.
Zurück zum Zitat Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ (2009) Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23(3):315–336CrossRefPubMed Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ (2009) Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23(3):315–336CrossRefPubMed
33.
Zurück zum Zitat Cuesta MJ, Peralta V, Zarzuela A (1998) Illness duration and neuropsychological impairments in schizophrenia. Schizophr Res 33(3):141–150CrossRefPubMed Cuesta MJ, Peralta V, Zarzuela A (1998) Illness duration and neuropsychological impairments in schizophrenia. Schizophr Res 33(3):141–150CrossRefPubMed
34.
Zurück zum Zitat Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ (2012) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry 13(5):318–378CrossRefPubMed Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ (2012) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry 13(5):318–378CrossRefPubMed
Metadaten
Titel
Driving skills in unmedicated first- and recurrent-episode schizophrenic patients
verfasst von
Felix M. Segmiller
Verena Buschert
Gerd Laux
N. Nedopil
Ulrich Palm
Katharina Furjanic
Peter Zwanzger
Alexander Brunnauer
Publikationsdatum
25.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 1/2017
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-015-0647-4

Weitere Artikel der Ausgabe 1/2017

European Archives of Psychiatry and Clinical Neuroscience 1/2017 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.